Table 1 Mean values ± SD of subjects’ continuous features considered
From: Predicting responsiveness to GLP-1 pathway drugs using real-world data
Features | Number of subjects | Mean value ± SD |
|---|---|---|
HbA1c decrease | 7856 | 0.50 ± 1.57 |
HbA1C before treatment | 7856 | 8.01 ± 1.72 |
HDL | 5635 | 43.35 ± 12.63 |
LDL | 5279 | 105.33 ± 74.50 |
Triglycerides | 5652 | 209.66 ± 162.08 |
Total cholesterol | 5713 | 176.45 ± 45.89 |
SGOT (AST) | 6480 | 29.24 ± 20.07 |
SGPT (ALT) | 6546 | 32.80 ± 25.90 |
C -peptide | 324 | 4.05 ± 3.22 |
Vitamin B12 | 1094 | 747.69 ± 926.74 |
Blood creatinine | 7191 | 1.07 ± 0.70 |
Fasting blood glucose | 1215 | 164.56 ± 62.13 |
Random glucose | 5922 | 174.97 ± 72.13 |
Urine glucose | 1745 | 30.97 ± 209.83 |
DBP | 7769 | 76.12 ± 9.99 |
SBP | 7769 | 132.90 ± 14.72 |
BMI | 7705 | 35.45 ± 8.07 |
Blood albumin | 6168 | 4.19 ± 0.36 |
Albumin /creatinine ratio | 4019 | 72.63 ± 265.25 |
Urine albumin | 4021 | 73.97 ± 256.83 |
Bicarbonate | 399 | 25.20 ± 5.29 |
Total blood protein | 3478 | 7.25 ± 0.52 |
Blood calcium | 7087 | 9.53 ± 0.48 |
Blood chloride | 7089 | 102.34 ± 3.36 |
Vitamin D 25OH | 1215 | 29.93 ± 14.05 |
Whole blood lactate | 265 | 1.50 ± 0.77 |
O2 saturation | 256 | 97.68 ± 3.10 |
Blood potassium | 7103 | 4.23 ± 0.42 |
Pulse | 6895 | 80.03 ± 12.06 |
Respiration rate | 3838 | 17.48 ± 3.43 |
Blood sodium | 7097 | 138.54 ± 2.59 |
Age | 7856 | 57.30 ± 11.90 |
T2D duration | 7856 | 3.36 ± 3.95 |